These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 11507075

  • 21. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.
    Meij P, Vervoort MB, Bloemena E, Schouten TE, Schwartz C, Grufferman S, Ambinder RF, Middeldorp JM.
    J Med Virol; 2002 Nov; 68(3):370-7. PubMed ID: 12226824
    [Abstract] [Full Text] [Related]

  • 22. [Recombinant AAV-LMP-induced LMP specific cytotoxic response to autologous lymphoblastoid cell lines tranformed by Epstein-Barr virus].
    Zhao F, Liu H, Zhou L, Cai W, Du B, Ye S, Zeng Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):247-51. PubMed ID: 15617340
    [Abstract] [Full Text] [Related]

  • 23. The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease.
    Bollard CM, Straathof KC, Huls MH, Leen A, Lacuesta K, Davis A, Gottschalk S, Brenner MK, Heslop HE, Rooney CM.
    J Immunother; 2004 Sep; 27(4):317-27. PubMed ID: 15235393
    [Abstract] [Full Text] [Related]

  • 24. Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15.
    Wagner HJ, Sili U, Gahn B, Vigouroux S, Huls MH, Xie W, Vignali D, Brenner MK, Heslop HE, Rooney CM.
    Cytotherapy; 2003 Sep; 5(3):231-40. PubMed ID: 12850791
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.
    Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M, Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE.
    J Exp Med; 2004 Dec 20; 200(12):1623-33. PubMed ID: 15611290
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH, Brestrich G, Mittenzweig A, Roemhild A, Zwinger S, Subklewe M, Beier C, Kurtz A, Babel N, Volk HD, Reinke P.
    J Immunother; 2007 Dec 20; 30(8):817-24. PubMed ID: 18049333
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Regulatory T cells and EBV associated malignancies.
    Li J, Qian CN, Zeng YX.
    Int Immunopharmacol; 2009 May 20; 9(5):590-2. PubMed ID: 19539572
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients.
    Audouin J, Diebold J, Pallesen G.
    J Pathol; 1992 Aug 20; 167(4):381-4. PubMed ID: 1328576
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
    Delsol G, Meggetto F, Brousset P, Cohen-Knafo E, al Saati T, Rochaix P, Gorguet B, Rubin B, Voigt JJ, Chittal S.
    Am J Pathol; 1993 Jun 20; 142(6):1729-38. PubMed ID: 7685151
    [Abstract] [Full Text] [Related]

  • 38. Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.
    Whitney BM, Chan AT, Rickinson AB, Lee SP, Lin CK, Johnson PJ.
    J Med Virol; 2002 Jul 20; 67(3):359-63. PubMed ID: 12116028
    [Abstract] [Full Text] [Related]

  • 39. Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition.
    Lee SP, Constandinou CM, Thomas WA, Croom-Carter D, Blake NW, Murray PG, Crocker J, Rickinson AB.
    Blood; 1998 Aug 01; 92(3):1020-30. PubMed ID: 9680372
    [Abstract] [Full Text] [Related]

  • 40. [High prevalence of the Epstein-Barr virus in a Mexican population with Hodgkin's disease].
    Quintanilla-Martínez L, Gamboa-Domínguez A, Gámez-Ledesma I, Orozco-Estévez H, Angeles-Angeles A.
    Rev Invest Clin; 1994 Aug 01; 46(5):355-62. PubMed ID: 7839015
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.